Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Redston

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseNabeel Bardeesy, Andrew J Aguirre, Gerald C Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2004
High-resolution characterization of the pancreatic adenocarcinoma genomeAndrew J Aguirre, Cameron Brennan, Gerald Bailey, et al.
Frontiers in Oncology|February 12, 2024
Development and evaluation of INT<sup>2</sup>GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndromeRaymond A Isidro, Anu Chittenden, McKenzie Walker, et al.
Plos Medicine|June 13, 2008
A mouse to human search for plasma proteome changes associated with pancreatic tumor developmentVitor M Faca, Kenneth S Song, Hong Wang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouseNabeel Bardeesy, Andrew J Aguirre, Gerald C Chu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 17, 2004
High-resolution characterization of the pancreatic adenocarcinoma genomeAndrew J Aguirre, Cameron Brennan, Gerald Bailey, et al.
Frontiers in Oncology|February 12, 2024
Development and evaluation of INT<sup>2</sup>GRATE: a platform for comprehensive assessment of the role of germline variants informed by tumor signature profile in Lynch syndromeRaymond A Isidro, Anu Chittenden, McKenzie Walker, et al.
Plos Medicine|June 13, 2008
A mouse to human search for plasma proteome changes associated with pancreatic tumor developmentVitor M Faca, Kenneth S Song, Hong Wang, et al.
Pageof 2